Raymond James & Associates’s Procept Biorobotics PRCT Stock Holding History

Raymond James & Associates’s Portfolio PRCT Stock Details PRCT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.27M	Buy
2024 Q2	$751K	Buy
2024 Q1	$492K	Buy